Cargando…

Glycosylation and the cystic fibrosis transmembrane conductance regulator

The cystic fibrosis transmembrane conductance regulator (CFTR) has been known for the past 11 years to be a membrane glycoprotein with chloride channel activity. Only recently has the glycosylation of CFTR been examined in detail, by O'Riordan et al in Glycobiology. Using cells that overexpress...

Descripción completa

Detalles Bibliográficos
Autores principales: Scanlin, Thomas F, Glick, Mary Catherine
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2001
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC59516/
https://www.ncbi.nlm.nih.gov/pubmed/11686896
http://dx.doi.org/10.1186/rr69
_version_ 1782120062528782336
author Scanlin, Thomas F
Glick, Mary Catherine
author_facet Scanlin, Thomas F
Glick, Mary Catherine
author_sort Scanlin, Thomas F
collection PubMed
description The cystic fibrosis transmembrane conductance regulator (CFTR) has been known for the past 11 years to be a membrane glycoprotein with chloride channel activity. Only recently has the glycosylation of CFTR been examined in detail, by O'Riordan et al in Glycobiology. Using cells that overexpress wild-type (wt)CFTR, the presence of polylactosamine was noted on the fully glycosylated form of CFTR. In the present commentary the results of that work are discussed in relation to the glycosylation phenotype of cystic fibrosis (CF), and the cellular localization and processing of ΔF508 CFTR. The significance of the glycosylation will be known when endogenous CFTR from primary human tissue is examined.
format Text
id pubmed-59516
institution National Center for Biotechnology Information
language English
publishDate 2001
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-595162001-11-06 Glycosylation and the cystic fibrosis transmembrane conductance regulator Scanlin, Thomas F Glick, Mary Catherine Respir Res Commentary The cystic fibrosis transmembrane conductance regulator (CFTR) has been known for the past 11 years to be a membrane glycoprotein with chloride channel activity. Only recently has the glycosylation of CFTR been examined in detail, by O'Riordan et al in Glycobiology. Using cells that overexpress wild-type (wt)CFTR, the presence of polylactosamine was noted on the fully glycosylated form of CFTR. In the present commentary the results of that work are discussed in relation to the glycosylation phenotype of cystic fibrosis (CF), and the cellular localization and processing of ΔF508 CFTR. The significance of the glycosylation will be known when endogenous CFTR from primary human tissue is examined. BioMed Central 2001 2001-08-07 /pmc/articles/PMC59516/ /pubmed/11686896 http://dx.doi.org/10.1186/rr69 Text en Copyright © 2001 BioMed Central Ltd
spellingShingle Commentary
Scanlin, Thomas F
Glick, Mary Catherine
Glycosylation and the cystic fibrosis transmembrane conductance regulator
title Glycosylation and the cystic fibrosis transmembrane conductance regulator
title_full Glycosylation and the cystic fibrosis transmembrane conductance regulator
title_fullStr Glycosylation and the cystic fibrosis transmembrane conductance regulator
title_full_unstemmed Glycosylation and the cystic fibrosis transmembrane conductance regulator
title_short Glycosylation and the cystic fibrosis transmembrane conductance regulator
title_sort glycosylation and the cystic fibrosis transmembrane conductance regulator
topic Commentary
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC59516/
https://www.ncbi.nlm.nih.gov/pubmed/11686896
http://dx.doi.org/10.1186/rr69
work_keys_str_mv AT scanlinthomasf glycosylationandthecysticfibrosistransmembraneconductanceregulator
AT glickmarycatherine glycosylationandthecysticfibrosistransmembraneconductanceregulator